Efficacy and safety of reduced thromboprophylaxis with low molecular weight heparin for hepatocellular carcinoma after conversion therapy

Efficacy and safety of reduced thromboprophylaxis with low molecular weight heparin for hepatocellular carcinoma after conversion therapy

Abstract Background Tyrosine kinase inhibitors (TKIs) impairs factor Xa (FXa)-mediated coagulation. This study aims to assess the safety and feasibility of reduced thromboprophylaxis with low molecular weight heparin (LMWH) for hepatocellular carcinoma (HCC) converted by Lenvatinib treatment. Method...

Full description

Saved in:
Bibliographic Details
Main Authors: Xu Zhang, Zhiguo Ai
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Gastroenterology
Subjects:
Anticoagulants
Hepatocellular carcinoma
Hepatectomy
Tyrosine kinase inhibitor
Venous thrombosis
Hemorrhage
Online Access:https://doi.org/10.1186/s12876-025-04208-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12876-025-04208-z

Similar Items